126 related articles for article (PubMed ID: 10490272)
1. Hemodynamic effect of the nitroxide superoxide dismutase mimics.
Hahn SM; Sullivan FJ; DeLuca AM; Bacher JD; Liebmann J; Krishna MC; Coffin D; Mitchell JB
Free Radic Biol Med; 1999 Sep; 27(5-6):529-35. PubMed ID: 10490272
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector.
Hahn SM; Krishna MC; DeLuca AM; Coffin D; Mitchell JB
Free Radic Biol Med; 2000 Mar; 28(6):953-8. PubMed ID: 10802227
[TBL] [Abstract][Full Text] [Related]
3. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
4. In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides.
Hahn SM; DeLuca AM; Coffin D; Krishna CM; Mitchell JB
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):839-42. PubMed ID: 9845107
[TBL] [Abstract][Full Text] [Related]
5. Tempol in the dorsomedial hypothalamus attenuates the hypertensive response to stress in rabbits.
De Matteo R; Head GA; Mayorov DN
Am J Hypertens; 2006 Apr; 19(4):396-402. PubMed ID: 16580576
[TBL] [Abstract][Full Text] [Related]
6. Negative inotropic and hypotensive effects of the superoxide dismutase mimetic tempol in pigs.
Kristensen MN; Frederiksen CA; Sivén E; Hyldebrandt JA; Juhl-Olsen P; Sloth E; Simonsen U; Buus NH
Eur J Pharmacol; 2014 May; 731():20-30. PubMed ID: 24632458
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol.
Mitchell JB; DeGraff W; Kaufman D; Krishna MC; Samuni A; Finkelstein E; Ahn MS; Hahn SM; Gamson J; Russo A
Arch Biochem Biophys; 1991 Aug; 289(1):62-70. PubMed ID: 1654848
[TBL] [Abstract][Full Text] [Related]
8. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide.
Schnackenberg CG; Welch WJ; Wilcox CS
Hypertension; 1998 Jul; 32(1):59-64. PubMed ID: 9674638
[TBL] [Abstract][Full Text] [Related]
9. Tempol, one of nitroxides, is a novel ultraviolet-A1 radiation protector for human dermal fibroblasts.
Yan SX; Hong XY; Hu Y; Liao KH
J Dermatol Sci; 2005 Mar; 37(3):137-43. PubMed ID: 15734282
[TBL] [Abstract][Full Text] [Related]
10. Potential use of nitroxides in radiation oncology.
Hahn SM; Krishna CM; Samuni A; DeGraff W; Cuscela DO; Johnstone P; Mitchell JB
Cancer Res; 1994 Apr; 54(7 Suppl):2006s-2010s. PubMed ID: 8137329
[TBL] [Abstract][Full Text] [Related]
11. Identification of nitroxide radioprotectors.
Hahn SM; Wilson L; Krishna CM; Liebmann J; DeGraff W; Gamson J; Samuni A; Venzon D; Mitchell JB
Radiat Res; 1992 Oct; 132(1):87-93. PubMed ID: 1410280
[TBL] [Abstract][Full Text] [Related]
12. The effect of tempol on endothelium-dependent vasodilatation and blood pressure.
Simonsen U; Christensen FH; Buus NH
Pharmacol Ther; 2009 May; 122(2):109-24. PubMed ID: 19268689
[TBL] [Abstract][Full Text] [Related]
13. Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension.
Patterson ME; Mouton CR; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F754-9. PubMed ID: 15900020
[TBL] [Abstract][Full Text] [Related]
14. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
[TBL] [Abstract][Full Text] [Related]
15. The nitroxide Tempol affords protection against ultraviolet radiation in a transgenic murine fibroblast culture model of cutaneous photoaging.
Bernstein EF; Kong SK; Brown DB; Kwak BC; Takeuchi T; Gasparro FP; Uitto J
Exp Dermatol; 2001 Feb; 10(1):55-61. PubMed ID: 11168580
[TBL] [Abstract][Full Text] [Related]
16. Renal and metabolic effects of tempol in obese ZSF1 rats--distinct role for superoxide and hydrogen peroxide in diabetic renal injury.
Rafikova O; Salah EM; Tofovic SP
Metabolism; 2008 Oct; 57(10):1434-44. PubMed ID: 18803950
[TBL] [Abstract][Full Text] [Related]
17. NO-independent mechanism mediates tempol-induced renal vasodilation in SHR.
de Richelieu LT; Sorensen CM; Holstein-Rathlou NH; Salomonsson M
Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1227-34. PubMed ID: 16033921
[TBL] [Abstract][Full Text] [Related]
18. Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats.
Nassar T; Kadery B; Lotan C; Da'as N; Kleinman Y; Haj-Yehia A
Eur J Pharmacol; 2002 Feb; 436(1-2):111-8. PubMed ID: 11834254
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia.
Rak R; Chao DL; Pluta RM; Mitchell JB; Oldfield EH; Watson JC
J Neurosurg; 2000 Apr; 92(4):646-51. PubMed ID: 10761655
[TBL] [Abstract][Full Text] [Related]
20. Effects of the superoxide dismutase-mimic compound TEMPOL on oxidant stress-mediated endothelial dysfunction.
Haj-Yehia AI; Nassar T; Assaf P; Nassar H; Anggård EE
Antioxid Redox Signal; 1999; 1(2):221-32. PubMed ID: 11228749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
